Evaluation and testing services (ETS) for vaccines

Closed Solicitation Posted

This opportunity was awarded. See its 12 award notices in the notice history.

Solicitation number
75N93024R00019
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Notice details come from SAM.gov. Updated .

About this opportunity

The National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, is seeking to establish a multiple award indefinite quantity contract to provide comprehensive evaluation and testing services for vaccines and other biologics targeting infectious diseases. The contract will require the successful offerors to have expertise, facilities, and resources to conduct preclinical, non-clinical, and clinical studies to support the development of promising vaccine and biologic candidates from academia, industry, and other sources. The technical proposals will be evaluated based on factors such as scientific and technical approach, project management, quality control, and personnel qualifications, with cost being secondary. Proposals are due by August 30, 2024.

This is an unrestricted solicitation with no set-aside designation. The contract has a minimum value of $10,000 and a maximum value of $136,588,701 over the 10-year period of performance from August 2025 to July 2035. The work will be performed at the contractor's facilities and potentially at government or third-party sites. The Government intends to award multiple contracts under this solicitation to ensure an adequate pool of qualified providers.

Notice text

2 versions

Update #2 · Latest ·

To provide evaluation and testing services to support preclinical, nonclinical, and clinical studies for promising candidate vaccines and other related biologics

Update #1 ·

To provide evaluation and testing services to support preclinical, nonclinical, and clinical studies for promising candidate vaccines and other related biologics

Files

Show all 22

Notice history

4 of 13 notices listed here. See the rest on GovTribe.

Similar open opportunities

Opportunity Agency Set-aside Responses due
2027 NIAID DMID Omnibus Broad Agency Announcement: Development of Medical Interventions for Infectious Diseases NAICS 541715 National Institute of Allergy and Infectious Diseases No set-aside
NAHLN Diagnostic Testing Services Ames, Iowa 50010, United States · NAICS 541940 Marketing and Regulatory Programs Business Services No set-aside
Request for Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response Washington, District of Columbia 20024, United States · NAICS 541714 Office of the Assistant Secretary for Preparedness and Response No set-aside
ARPA-H Emerging Health Innovators (EHI) Initiative District of Columbia 20003, United States · NAICS 541714 National Institutes of Health No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity